CIK 0001802255 · Accelerated filer
Guardian Pharmacy Services, Inc.
Sign in to watch- Ticker
- GRDN
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- GA
- Entity type
- operating
- EIN
- 200100834
- Phone
- (404) 810-0089
- Business address
- 300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA, GA, 30339
- Former names
- Guardian Pharmacy Services, Inc., Guardian Pharmacy, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-28 | BINDLEY WILLIAM E Director | Option exercise · Class B Common Stock | −6,100,175 | 6,100,175 | ||
| 2026-03-28 | Cardinal Equity Fund, L.P. Member of 10% owner group | Option exercise | +471,057 | 816,180 | ||
| 2026-03-28 | Cardinal Equity Fund, L.P. Member of 10% owner group | Option exercise · Class B Common Stock | −471,057 | 471,057 | ||
| 2026-03-28 | Salentine Thomas J Jr Director | Option exercise | +6,100,175 | 10,569,491 | ||
| 2026-03-28 | Salentine Thomas J Jr Director | Option exercise · Class B Common Stock | −6,100,175 | 6,100,175 | ||
| 2026-03-28 | Forbes Kendall See Remarks | Option exercise | +608,570 | 1,061,826 | ||
| 2026-03-28 | Forbes Kendall See Remarks | Option exercise · Class B Common Stock | −608,570 | 608,570 | ||
| 2026-03-28 | Morris David K See Remarks | Option exercise | +641,869 | 896,341 | ||
| 2026-03-28 | Morris David K See Remarks | Option exercise · Class B Common Stock | −641,869 | 641,870 | ||
| 2026-03-28 | Bindley Capital Partners I, LLC 10% owner | Option exercise | +6,100,175 | 10,569,491 | ||
| 2026-03-28 | Bindley Capital Partners I, LLC 10% owner | Option exercise · Class B Common Stock | −6,100,175 | 6,100,175 | ||
| 2026-03-28 | Ackerman John Director | Option exercise | +1,413,939 | 2,449,867 | ||
| 2026-03-28 | Ackerman John Director | Option exercise | +471,057 | 816,180 | ||
| 2026-03-28 | Ackerman John Director | Option exercise · Class B Common Stock | −1,413,939 | 1,413,939 | ||
| 2026-03-28 | Ackerman John Director | Option exercise · Class B Common Stock | −471,057 | 471,057 | ||
| 2026-03-28 | Burke Fred See Remarks | Option exercise | +1,298,826 | 2,139,239 | ||
| 2026-03-28 | Burke Fred See Remarks | Option exercise · Class B Common Stock | −1,298,826 | 1,298,825 | ||
| 2026-03-20 | Morris David K See Remarks | Sale | −187,855 | $29.68 | $5.6M | 254,472 |
| 2026-03-20 | Pharmacy Investors, LLC Member of 10% owner group | Sale | −827,636 | $29.68 | $24.6M | 1,035,928 |
| 2026-03-20 | Burke Fred See Remarks | Sale | −671,432 | $29.68 | $19.9M | 840,413 |
Page 3 of 8 · 149 trades